WKHS Locations

Clinical Trials

N9831

Study Title

N9831

Purpose

A treatment for women with HER-2 overexpressing positive breast cancer.

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

Robert Nickelson, M.D.

IRB:

Willis-Knighton

IRB Number:

02.0270

Trial Type:

Drug

Sponsor:

SWOG (southwest Oncology Group)

Contact Information:

Hematology Oncology Associates
(318) 212-3702
http://cancer.wkhs.com